Mineralys Therapeutics, Inc.
MLYS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001933414
In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Mineralys Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 215 | 2 | 225 | +12 |
| Shares | 90.3M | 25.9K | 99.7M | +9.34M (+10.3%) |
| Value | $2.46B | $701.2K | $2.69B | +$234.1M (+9.5%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (23)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Caligan Partners LP | 2,772,654 | $75.1M |
| Point72 Asset Management, L.P. | 1,911,433 | $51.8M |
| Lord, Abbett & Co. LLC | 300,913 | $8.15M |
| Findell Capital Management LLC | 202,000 | $5.47M |
| Buckley Capital Advisors, LLC | 173,100 | $4.69M |
| Y-Intercept (Hong Kong) Ltd | 132,099 | $3.58M |
| Swedbank AB | 122,100 | $3.31M |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 104,961 | $2.84M |
| J. Goldman & Co LP | 94,101 | $2.55M |
| Susquehanna Portfolio Strategies, LLC | 78,092 | $2.12M |
| Seven Fleet Capital Management LP | 69,571 | $1.88M |
| Raymond James Financial Inc | 24,677 | $668.5K |
| Allianz Asset Management GmbH | 21,900 | $593.3K |
| Nomura Holdings Inc | 20,000 | $541.8K |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 19,689 | $533.4K |
| Fox Run Management, L.L.C. | 12,670 | $297.9K |
| VARCOV Co. | 9,759 | $264.4K |
| Kingswood Wealth Advisors, LLC | 9,600 | $260.1K |
| Advisory Services Network, LLC | 41 | $1.11K |
| Clearstead Advisors, LLC | 11 | $298 |
| Basecamp Wealth Advisors LLC | 6 | $163 |
| Quadrant Capital Group LLC | 5 | $136 |
| JPL Wealth Management, LLC | 3 | $82 |
Not filed for Q2 2026 yet (2)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 19,848 | $537.3K |
| CWM, LLC | 6,051 | $163.9K |